141 related articles for article (PubMed ID: 25844750)
1. Concern about the use of venlafaxine to treat vasomotor symptoms.
Zhou SS; Lun YZ; Li D
JAMA Intern Med; 2015 Apr; 175(4):657-8. PubMed ID: 25844750
[No Abstract] [Full Text] [Related]
2. Concern about the use of venlafaxine to treat vasomotor symptoms--reply.
Joffe H; LaCroix AZ; Cohen L
JAMA Intern Med; 2015 Apr; 175(4):658-9. PubMed ID: 25844753
[No Abstract] [Full Text] [Related]
3. Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.
Joffe H; Guthrie KA; LaCroix AZ; Reed SD; Ensrud KE; Manson JE; Newton KM; Freeman EW; Anderson GL; Larson JC; Hunt J; Shifren J; Rexrode KM; Caan B; Sternfeld B; Carpenter JS; Cohen L
JAMA Intern Med; 2014 Jul; 174(7):1058-66. PubMed ID: 24861828
[TBL] [Abstract][Full Text] [Related]
4. Venlafaxine hydrochloride for the treatment of hot flashes.
Schober CE; Ansani NT
Ann Pharmacother; 2003 Nov; 37(11):1703-7. PubMed ID: 14565812
[TBL] [Abstract][Full Text] [Related]
5. Nonhormonal agents show promise against hot flashes.
Gottlieb N
J Natl Cancer Inst; 2000 Jul; 92(14):1118-20. PubMed ID: 10904081
[No Abstract] [Full Text] [Related]
6. Venlafaxine for hot flushes.
Barlow DH
Lancet; 2000 Dec; 356(9247):2025-6. PubMed ID: 11145483
[No Abstract] [Full Text] [Related]
7. Beyond estrogen: new alternatives for the management of hot flashes.
Dvorak SR
S D J Med; 2002 Jan; 55(1):11-2. PubMed ID: 11808405
[No Abstract] [Full Text] [Related]
8. Medroxyprogesterone acetate better than venlafaxine at relieving hot flashes.
J Support Oncol; 2005; 3(4):312. PubMed ID: 16092603
[No Abstract] [Full Text] [Related]
9. Breast cancer and hot flashes. Options for relief.
Mayo Clin Health Lett; 2001 Mar; 19(3):6. PubMed ID: 11242843
[No Abstract] [Full Text] [Related]
10. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7.
Loprinzi CL; Levitt R; Barton D; Sloan JA; Dakhil SR; Nikcevich DA; Bearden JD; Mailliard JA; Tschetter LK; Fitch TR; Kugler JW
J Clin Oncol; 2006 Mar; 24(9):1409-14. PubMed ID: 16505409
[TBL] [Abstract][Full Text] [Related]
11. Treatment for hot flushes in women receiving tamoxifen.
Bydder SA; Spry NA
Med J Aust; 2002 Sep; 177(5):266. PubMed ID: 12197825
[No Abstract] [Full Text] [Related]
12. Desvenlafaxine: a therapeutic option for treatment of menopausal hot flashes.
Archer DF
Maturitas; 2010 May; 66(1):1-2. PubMed ID: 20211532
[No Abstract] [Full Text] [Related]
13. Sexual function in women on estradiol or venlafaxine for hot flushes: a randomized controlled trial.
Reed SD; Mitchell CM; Joffe H; Cohen L; Shifren JL; Newton KM; Freeman EW; Larson JC; Manson JE; LaCroix AZ; Guthrie KA
Obstet Gynecol; 2014 Aug; 124(2 Pt 1):233-241. PubMed ID: 25004335
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of venlafaxine and selective serotonin reuptake inhibitors with zolpidem improves sleep and quality of life in breast cancer patients with hot flashes: a randomized, double-blind, placebo-controlled trial.
Joffe H; Partridge A; Giobbie-Hurder A; Li X; Habin K; Goss P; Winer E; Garber J
Menopause; 2010; 17(5):908-16. PubMed ID: 20581724
[TBL] [Abstract][Full Text] [Related]
15. Flushing in a menopausal woman taking venlafaxine.
Grady-Weliky TA; Hartmann DM
Am J Psychiatry; 2001 Aug; 158(8):1330. PubMed ID: 11481177
[No Abstract] [Full Text] [Related]
16. Venlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients--a double-blind, randomized study.
Loibl S; Schwedler K; von Minckwitz G; Strohmeier R; Mehta KM; Kaufmann M
Ann Oncol; 2007 Apr; 18(4):689-93. PubMed ID: 17229772
[TBL] [Abstract][Full Text] [Related]
17. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
[TBL] [Abstract][Full Text] [Related]
18. Noradrenergic and serotonergic modulation to treat vasomotor symptoms.
Albertazzi P
J Br Menopause Soc; 2006 Mar; 12(1):7-11. PubMed ID: 16513016
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of desvenlafaxine succinate for menopausal hot flashes.
Tella SH; Gallagher JC
Expert Opin Pharmacother; 2014 Nov; 15(16):2407-18. PubMed ID: 25252697
[TBL] [Abstract][Full Text] [Related]
20. Venlafaxine alters microvascular perfusion, [¹²³I]-beta-CIT binding and BDI scores in flushing postmenopausal women.
Sassarini J; Krishnadas R; Cavanagh J; Nicol A; Pimlott SL; Ferrell W; Lumsden MA
Maturitas; 2014 Mar; 77(3):267-73. PubMed ID: 24411555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
